HIV drug resistance surveillance for prioritizing treatment in resource-limited settings-Reference-Cited by-同舟云学术

HIV drug resistance surveillance for prioritizing treatment in resource-limited settings

Published:2007-05-11 Issue:8 Volume:21 Page:973-982
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Walensky Rochelle P,Weinstein Milton C,Yazdanpanah Yazdan,Losina Elena,Mercincavage Lauren M,Touré Siaka,Divi Nomita,Anglaret Xavier,Goldie Sue J,Freedberg Kenneth A

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference21 articles.

1. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda;Spacek;Clin Infect Dis,2006

2. HIV antiretroviral drug resistance in Africa;Nkengasong;AIDS Rev,2004

3. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis;Yazdanpanah;AIDS,2005

4. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis;Sax;Clin Infect Dis,2005

5. The cost-effectiveness of preventing AIDS-related opportunistic infections;Freedberg;JAMA,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging antiretroviral drug resistance in sub-Saharan Africa;AIDS;2014-11-28

2. Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis;The Lancet HIV;2014-11

3. Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings;PLoS ONE;2014-10-07

4. Transmission of Drug Resistant HIV and Its Potential Impact on Mortality and Treatment Outcomes in Resource-Limited Settings;The Journal of Infectious Diseases;2013-06-15

5. Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal;PLoS ONE;2012-09-17